Abstract:Exosome-based liquid biopsy holds great potential in monitoring tumor progression. Current exosome detection biosensors rely on signal amplification strategies to improve sensitivity; however, these strategies pay little attention to manipulating the number of signal reporters, limiting the rational optimization of the biosensors. Here, we have developed a modularized surface-enhanced Raman spectroscopy (SERS) labeling strategy, where each Raman reporter is coupled with lysine as a signal-lysine module, and thus the number of Raman reporters can be precisely controlled by the modularized solid-phase peptide synthesis. Using this strategy, we screened out an optimum Raman biosensor for ultrasensitive exosome detection, with the limit of detection of 2.4 particles per microliter. This biosensor enables a successful detection of the tumor with an average diameter of approximately 3.55 mm, and thus enables successful surveillance of the postoperative tumor recurrence in mice models and distinguishing cancer patients from healthy subjects. Our work provides a de novo strategy to precisely amplify signals toward a myriad of biosensor-related medical applications.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acssensors.1c00890.Experimental details; preparation and characterization of exosomes (Figure S1); preparation and characterization of compound 1 (Figure S2); characterization of the EpCAM aptamer carrying single Raman reporter (Figure S3); detection of A549 cells derived exosomes by SERS EpCAM-aptasensors carrying single Raman reporter and SERS random sequence-sensors carrying single Raman reporter (Figure S4); mass spectra of signal amplified parts carrying (a) 5, (b) 8, and (c) 10 Raman reporters (Figure S5); gel electrophoresis image for EpCAM aptamer carrying eight Raman reporters (Figure S6); quantitative analysis of A549 cell-derived exosomes by ELISA (Figure S7); linear range of exosome detection in plasma by SERS EpCAM-aptasensors carrying eight Raman reporters (Figure S8); stability of the SERS EpCAM-aptasensors for plasma exosome detection (6.00 × 107/mL) in three consecutive weeks (Figure S9); and correlation of the SERS signal with the tumor size of NSCLC mice models (Figure S10). Tables S1–S5 (PDF)This article has not yet been cited by other publications.

SERS Lateral Flow Strip Detection of Serum Biomarkers for Noninvasive Assessment of Operative Microwave Ablation Outcomes of Unresectable Hepatocellular Carcinoma

Quantitative SERS Detection of Serum Protein Biomarkers for Assessment of Tumor Microwave Ablation Outcomes

Predicting Early Intrahepatic Recurrence of Hepatocellular Carcinoma after Microwave Ablation Using Seldi-Tof Proteomic Signature

Ultrasensitive, Multiplex Raman Frequency Shift Immunoassay of Liver Cancer Biomarkers in Physiological Media.

Surface-enhanced Raman scatting microfluidic chip based on the identification competition strategy were used for rapid and simultaneous detection of liver cancer related proteins

Frequency Shift Raman-Based Sensing of Serum MicroRNAs for Early Diagnosis and Discrimination of Primary Liver Cancers.

Combined SERS Microfluidic Chip with Gold Nanocone Array for Effective Early Lung Cancer Prognosis in Mice Model

Pump-free microfluidic chip based laryngeal squamous cell carcinoma-related microRNAs detection through the combination of surface-enhanced Raman scattering techniques and catalytic hairpin assembly amplification

Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma.

Highly Sensitive and Simultaneous Detection of Ctdnas Related to Non-Small Cell Lung Cancer in Serum Using a Catalytic Hairpin Assembly Strategy in a SERS Microfluidic Chip.

Ultra-sensitive and high efficiency detection of multiple non-small cell lung cancer-related miRNAs on a single test line in catalytic hairpin assembly-based SERS-LFA strip.

Interference-free and High Precision Biosensor Based on Surface Enhanced Raman Spectroscopy Integrated with Surface Molecularly Imprinted Polymer Technology for Tumor Biomarker Detection in Human Blood

Highly Sensitive Detection Of Cytochrome C In The Nsclc Serum Using A Hydrophobic Paper Based-Gold Nanourchin Substrate

Early Assessment of Chemotherapeutic Response in Hepatocellular Carcinoma Based on Serum Surface-Enhanced Raman Spectroscopy.

Target-triggered assembly of plasmon resonance nanostructures for quantitative detection of lncRNA in liver cancer cells via surface enhanced Raman spectroscopy

Ultrasensitive Exosome Detection by Modularized SERS Labeling for Postoperative Recurrence Surveillance

Multiplex Immunochips for High-Accuracy Detection of Afp-L3% Based on Surface-Enhanced Raman Scattering: Implications for Early Liver Cancer Diagnosis

Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Accurate Clinical Diagnosis of Liver Cancer Based on Simultaneous Detection of Ternary Specific Antigens by Magnetic Induced Mixing Surface-Enhanced Raman Scattering Emissions.

Fiber Laser-Based Lasso-Shaped Biosensor for High Precision Detection of Cancer Biomarker-CEACAM5 in Serum.

Highly Sensitive and Reliable Detection of Microrna for Clinically Disease Surveillance Using SERS Biosensor Integrated with Catalytic Hairpin Assembly Amplification Technology.